Fabiane Motter

Dr. Fabiane Motter

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2018 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
FMFabiane Motter
Fabiane Motter
JFJanaína Soder Fritzen
Janaína Soder Fritzen
SHSarah Nicole Hilmer
Sarah Nicole Hilmer
ÉPÉrika Vieira Paniz
Érika Vieira Paniz
VPVera Maria Vieira Paniz
Vera Maria Vieira Paniz

1 April 2021 in Ciencia & Saude Coletiva
Verified
Journal Article
Open access
PDF file
VAVitória Andretta
Vitória Andretta
JSJosiane Siviero
Josiane Siviero
KMKarina Giane Mendes
Karina Giane Mendes
FMFabiane Motter
Fabiane Motter
HTHeloísa Theodoro
Heloísa Theodoro
Resumo O estudo tem por objetivo analisar o consumo de alimentos ultraprocessados relacionando com fatores sociodemográficos, comportamentais e nutricionais em escolares da rede municipal de ensino de Caxias do Sul-RS. Trata-se de um estudo transversal, com 1.309 escolares na faixa etária entre 6 e 16 anos. O consumo de alimentos ultraprocessados foi obtido por meio de um questionário de acordo com o autorrelato do escolar. Utilizou-se um questionário pré-testado para avaliar as características do escolar e dos familiares. Utilizou-se a regressão de Poisson para análise do desfecho e fatores associados por meio de um modelo hierárquico. Considerou-se estatisticamente significtivos resultados com valor p ≤ 0,05. Resultados: Identificou-se elevada prevalência de consumo de alimentos ultraprocessados entre os escolares (69,7%). Após análise ajustada, maiores prevalências de consumo de alimentos ultraprocessados foram associadas a comprar/levar lanche para escola e realizar lanches. Já o aconselhamento nutricional foi associado à proteção em relação ao consumo destes alimentos. Conclusão: Fazem-se necessárias ações de educação nutricional para escolares e responsáveis a fim de reduzir o consumo de alimentos ultraprocessados pelos escolares principalmente nos lanches.

2 December 2019 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
FMFabiane Motter
Fabiane Motter
SHSarah Nicole Hilmer
Sarah Nicole Hilmer
VPVera Maria Vieira Paniz
Vera Maria Vieira Paniz
Purpose: The aim of the present study was to develop and validate a Potentially Inappropriate Medications (PIM) list and alternative therapies for treatment of pain and inflammation in older people adapted to the Brazilian context. Methods: A preliminary PIM list suitable for the Brazilian market was developed on the basis of three published international PIM lists [Beers 2015, Screening Tool of Older People’s Potentially Inappropriate Prescriptions - 2015, European Union (7) PIM list]. We used the modified Delphi technique (two-round) to validate concerns of use and alternative therapies related to PIM for treatment of pain and inflammation in older adults ≥65 years in Brazil. The panel involved nine Brazilian experts in geriatric pharmacotherapy. All items with mean Likert scale score ≥4.0 (agree) and the lower limit of 95% confidence interval ≥4.0 were considered validated in this study. Results: At the end of the consensus process, 94 (65.3%) items of 144 were validated. In total, consensus was reached for 33/35 (94.3%) concerns about drugs that should be avoided in older patients regardless of diagnosis, for 22/23 (95.7%) concerns about drugs that should be avoided in older patients with specific conditions or diseases, for 11/23 (47.8%) with special considerations of use, and for 28/63 (44.4%) of therapeutic alternatives. Conclusion: Although these criteria are not designed to replace clinical judgement, PIM and alternative therapies lists can be useful to inform prescribers, pharmacists, and health care planners and may serve as a starting point for safe and effective use of medications in older people.

2 August 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
FMFabiane Motter
Fabiane Motter
NCNathalia Margarida Cantuaria
Nathalia Margarida Cantuaria
LLLuciane Cruz Lopes
Luciane Cruz Lopes
Background: Deprescribing is the planned and supervised process of dose reduction or stopping of medication that might be causing harm, or no longer be of benefit. It is an activity that should be a normal part of care/the prescribing cycle. Although now broadly recognised, there are still challenges in its effective implementation.Objectives: To develop and validate an instrument to measure Brazilian healthcare professionals’ knowledge, attitudes and practices towards deprescribing.Methods: This study will include the following steps: (1) development of the preliminary instrument; (2) content validation; (3) pilot study; (4) evaluation of psychometric characteristics. After the elaboration of items of the instrument through the literature review, we will use a hybrid Delphi method to develop and establish the content validity of the instrument. Further, a pilot survey will be performed with 30 healthcare professionals. Finally, for the evaluation of psychometric characteristics, a cross-sectional study will be accomplished with a representative sample of different healthcare professionals from different Brazilian states using respondent-driven sampling. Exploratory factor analysis and confirmatory factor analysis will be performed. For assessing the model fit, we will use the ratio of χ2 and df (χ2/df), comparative fit index, the goodness of fit index and root mean square error of approximation. In addition, the reliability of the instrument will be estimated by test–retest reproducibility and Cronbach’s alpha coefficient (α).Ethics and dissemination: The Ethics Committee for Research at the University of Sorocaba (ethics approval number: 3.848.916) approved the study. Study findings will be circulated to healthcare professionals and scientists in the field through publication in peer-reviewed journals and conference presentations.

27 November 2017 in Revista de Saúde Pública
Verified
Journal Article
Open access
PDF file
JFJanaína Soder Fritzen
Janaína Soder Fritzen
FMFabiane Motter
Fabiane Motter
VPVera Maria Vieira Paniz
Vera Maria Vieira Paniz
To investigate the prevalence of the adherence to the medications of the Specialized Component of Pharmaceutical Services and its association with regular access in users of these medications in the municipality of São Leopoldo, State of Rio Grande do Sul, Brazil. This is a cross-sectional study with adults aged 20 years and over, who are users of medications of the Specialized Component of Pharmaceutical Services. Sampling was carried out consecutively for users who accessed the service of the Specialized Component of Pharmaceutical Services during the period from December 2014 to March 2015. Adherence was measured by the Brief Medication Questionnaire, and adherents were defined as those who did not present barriers to adherence in the three domains. Regular access was defined as getting all medications in the last three months, regardless of how it was obtained (paying or for free). Data analysis was performed using Poisson regression with robust variance. We interviewed 414 subjects, being them mostly women (60.9%), with mean age of 55 years (SD = 13), and using a single medication of the Specialized Component of Pharmaceutical Services (68.1%). The prevalence of adherence to the medications used in the last seven days was 28.3% and the prevalence of free regular access was 46.1%, and 25.7% did not have access to all treatment. After adjusting for the number of medications in the Specialized Component of Pharmaceutical Services and the number of medications of continuous use, users who had free regular access in the last three months were 60% more likely to show adherence. For individuals with paid regular access, no association was found between access and adherence. The regularity in the free access to the medications of the Specialized Component of Pharmaceutical Services has an impact on the behavior of users, contributing to their commitment to treatment and self-care. The Specialized Component of Pharmaceutical Services needs programming in order to avoid irregular access, which suggests a significant limitation of the drug policies in Brazil.

26 March 2021 in Medicine
Verified
Journal Article
Open access
TFTânia Regina Ferreira
Tânia Regina Ferreira
LLLuciane Cruz Lopes
Luciane Cruz Lopes
FMFabiane Motter
Fabiane Motter
CBCristiane de Cássia Bergamaschi
Cristiane de Cássia Bergamaschi
Older adults are the leading users of medications, where this can be associated with a high number of potentially inappropriate medications (PIMs) and of potentially inappropriate prescribing (PIP) and consequent harm to health. No Brazilian study evaluating potentially inappropriate prescribing in older patients with Alzheimer's disease (AD) was found. This study determined and analyzed the prevalence of PIP and PIM prescribed for older people with AD. A cross-sectional study was carried out at the Specialty Drugs Pharmacy in the city of Sorocaba, São Paulo State, Brazil. The MEDEX system provided the register in older people with AD and data were collected during interviews with patients and/or caregivers between June and September 2017. The PIMs were identified according to the 2019 Beers Criteria. The association between PIMs and independent variables was analyzed by Poisson regression. This study included 234 older patients with AD. The prevalence of PIP prescribed was 66.7% (n = 156). Of the 1073 medications prescribed, 30.5% (n = 327) were inappropriate with most affecting the central nervous system or cardiovascular, particularly quetiapine (12.8%) and acetylsalicylic acid (11.6%), respectively. Around 45.2% of the PIMs should be avoided in older people, especially sertraline (14.2%) and clonazepam (7.4%). After adjusted analysis, the PIMs were associated with the diagnosis of depression (P = 0.010) and the number of comorbidities (P = 0.005). There was a high number of PIMs among older people, a substantial number of which should have been avoided in this population. Health care professionals can apply these findings to improve safety in the use of medications for treating patients with AD.